Chemical genetic approach identifies microtubule affinity‐regulating kinase 1 as a leucine‐rich repeat kinase 2 substrate. Issue 7 (8th April 2015)

• Record Type: Journal Article
• Authors: Krumova, Petranka; Reyniers, Lauran; Meyer, Marc; Lobbestael, Evy; Stauffer, Daniela; Gerrits, Bertran; Muller, Lionel; Hoving, Sjouke; Kaupmann, Klemens; Voshol, Johannes; Fabbro, Doriano; Bauer, Andreas; Rovelli, Giorgio; Taymans, Jean‐Marc; Bouwmeester, Tewis; Baekelandt, Veerle
• Is Part Of: FASEB journal. Volume 29:Issue 7(2015)
• Page Start: 2980
• Page End: 2992
• Publication Date: 2015-04-08
• Subjects: cellular signaling -- gatekeeper kinase -- neuroscience -- Parkinson's disease; Biology -- Periodicals; Biology, Experimental -- Periodicals; 570
• DOI: 10.1096/fj.14-262329
• Languages: English
• ISSNs: 0892-6638

Abstract

ABSTRACT: Mutations in leucine‐rich repeat kinase 2 (LRRK2) are the most common cause of autosomal‐dominant forms of Parkinson's disease. LRRK2 is a modular, multidomain protein containing 2 enzymatic domains, including a kinase domain, as well as several protein‐protein interaction domains, pointing to a role in cellular signaling. Although enormous efforts have been made, the exact pathophysiologic mechanisms of LRRK2 are still not completely known. In this study, we used a chemical genetics approach to identify LRRK2 substrates from mouse brain. This approach allows the identification of substrates of 1 particular kinase in a complex cellular environment. Several of the identified peptides are involved in the regulation of microtubule (MT) dynamics, including microtubule‐associating protein (MAP)/microtubule affinity‐regulating kinase 1 (MARK1). MARK1 is a serine/threonine kinase known to phosphorylate MT‐binding proteins such as Tau, MAP2, and MAP4 at KXGS motifs leading to MT destabilization. In vitro kinase assays and metabolic‐labeling experiments in living cells confirmed MARK1 as an LRRK2 substrate. Moreover, we also showed that LRRK2 and MARK1 are interacting in eukaryotic cells. Our findings contribute to the identification of physiologic LRRK2 substrates and point to a potential mechanism explaining the reported effects of LRRK2 on neurite morphology.—Krumova, P., Reyniers, L., Meyer, M., Lobbestael, E., Stauffer, D., Gerrits, B., Muller, L., Hoving, S., Kaupmann, K., Voshol, J., Fabbro, D., Bauer, A., Rovelli, G., Taymans, J.‐M., Bouwmeester, T., Baekelandt, V. Chemical genetic approach identifies microtubule affinity‐regulating kinase 1 as a leucine‐rich repeat kinase 2 substrate. FASEB J . 29, 2980‐2992 (2015). www.fasebj.org